Safety and Tolerability of SHR-1316 in Subjects With Advanced Tumors
Clinical trial NCT03474289 · UNKNOWN
Trial details
- NCT number
- NCT03474289
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-01
- Primary completion
- 2019-01-30
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.